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ABSTRACT
Chronic testosterone (T) treatments induced male-like aggressive behavior
m ovariectomized adult C57BL/6 female mice. However, non-aromatizeable
androgen (5a-dihydrotestosterone (DHT) and methyltrienolone (RI88I», estrogen
(estradiol benzoate (BB», as well as combined DHT and EB treatments up to a
maximum 40 days did not exert any behavioral effect. This study was conducted
to determine whether the differences in C57BL/6 females' behavioral responses to
T and DHT treatments might be due to differences in the intracellular actions of
the two ligands at the androgen receptor binding level. To this purpose, binding
of the two androgens as measured by in vitro incubation with hypothalamic cytosol
from 48 hour ovariectomized adult (70-90 days old) C57BL/6 female mice. The
possibility of multiple DHT binding sites in the cytosol was also analyzed by 10-
25% sucrose gradient centrifugation. The displacement results showed there was
a low affmity, non-saturable DHT binding site(s) that was suppressed in the
presence of excess T. This fmding was confirmed by subsequent sucrose gradient
centrifugation analysis. The sedimentation coefficient of this DHT binding site(s)
was smaller than the specific androgen binding site in the cytosol. The significance
of this fmding in adult C57BL/6 female's resistance to the aggression-prompting
properties of DHT was discussed.
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INTRODUCTION
This thesis presents [mdings from in vitro androgen binding studies with
preoptic-hypothalamic-septal cytosol from adult C57BL/6 female mice. The
experiments were designed to investigate possible cellular androgen receptor
binding defects that are responsible for C57BL/6 females' insensitivity to the
aggression-prompting property of non-aromatizable androgens (Simon and
Masters, 1987). The background of this study embraces behavioral,
neuroendocrinological and molecular endocrinological studies. Behavioral and
neuroendocrinological studies on androgen-dependent aggression were reviewed
under "Sexual Hormones and Aggression," and "Hypothalamus and Aggression."
Causes for steroid hormone insensitivity are discussed in "Steroid Hormone
Resistance." A brief description of molecular mechanisms of steroid hormone
function is given in the following paragraphs.
Steroid Hormone Action
The body survives by adjusting itself to the everchanging environment.
Species that could not keep up the pace of change disappeared; those who could
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developed sophisticated nervous and endocrine systems to control the body's
response to external and internal changes. The basic function of both the nervous
endocrine systems is the same: to communicate one part of the body to another
such that tissues can act coordinately. The mechanisms employed by the two
systems, however, are fundamentally different. Nerver systems stimulate or
inhibit an organism's function with electrical impulses conducted through
networks of neuron. Responses to nerve impulses come in fractions of a second.
The endocrine system works through honnones secreted from glands into the
general circulation, and its effects can require hours or days for expression.
Though slower in effect, the actions of endocrine systems have a longer-
lasting effect than that of nervous systems. Endocrine glands respond to the
levels of chemicals or other honnones in the bloodstream, or nerve impulses from
the brain. This multiple-action communication system allows for control of slow,
continuous processes such as the body's growth, sexual characteristics, arousal,
sexual behavior, reproduction, mood changes, and metabolism.
Secreted from testes (T), ovaries ~ and Progesterone) and adrenal
(Cortisol), steroid honnones are transported in plasma bound to carrier proteins
(see Wesphal, 1983; and Siiteri et al., 1982 for reviews). These carrier proteins
include the steroid-binding glycoprotein transcortin (corticosteroid-binding
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globulin, CBG, binds glucocorticoid and progestin) and sex hormone-binding
globulin (SHBG, binds androgens and estrogens). They protect the hormones
from premature degradation and make them more soluble in serum.
No conclusive evidence for specific binding sites or trans-membrane
channels have been reported for steroids on their target cell membranes. There
is, however, evidence for specific binding sites on steroid hormone target cell
membrane for serum steroid binding proteins. These membrane binding sites may
provide an active role for serum steroid binding proteins in increasing local
concentration of steroid hormone surrounding their target cells (Singer, Khan and
Rosner, 1988; Avvakumov, Zhuk and Strel'chyonok, 1986; Hryb, Khan, Romas
and Rosner, 1986; Hryb, Khan and Rosner, 1985; Strel'chyonok and Avvakumov,
1983; Szego and Pietras, 1981, review). Being small hydrophobic molecules, free
steroid hormones diffuse into and out of adjacent cells passively. Once inside a
target cell, steroid hormones bind with their specific intracellular binding protein,
the steroid hormone receptor. Because of the receptor binding, concentrations of
free steroids in the cell plasma decreased therefore more hormones will then
diffuse into the target cell. This passive diffusion theory was supported by
evidence that showed correlations between steroid honnone tissue uptake and
honnone receptor binding affmity (Carlson and Katzenellenbogen, 1990).
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Subcellular locations of steroid receptor are unclear. The conventional
notion had been that unoccupied receptors existed in cytoplasm and were
translocated to the nucleus after hormone binding (see Katzenellenbogen, 1980,
for review). Recent studies using receptor antibodies suggested that androgen
receptors are predominantly in the nucleus either in the presence or in the absence
of androgen ligand (Tilley, Marcelli and McPhaul, 1990, review; Brenner, West,
Chang and Liao, 1989; Liao, Kokontis, Sai and Hiipakka, 1989, review; Tan et
al., 1988;). A dynamic equilibrium between the cytoplasmic and nuclear
compartments of the receptors was also suggested (Katzenellenbogen, 1980).
The high level structures of different steroid hormone receptors are very
similar to each other as revealed by their cDNAs (Lubahn et al., 1988; Tan et al.,
1988; Misrahi et al., 1987; Greene, Gilna, Waterfield, Baker, Hort and Shine,
1986; Hollenberg et al., 1985). All steroid hormone receptors have a short,
highly conserved, DNA binding domain, a hydrophobic steroid binding domain
at their carboxyI terminal and a less well-characterized amino terminal domain
(Mulder et al., 1989; Evans, 1988; Carlstedt-Duke, Stromstedt, Wrange, Bergman,
Gustafsson and Jomvall, 1987; de Boer, Bolt and Kuiper, 1987; Hollenberg,
Giguere, Segui and Evans, 1987; Giguere, Hollenberg, Rosenfeld and Evans,
1986). Unoccupied receptors have low non-specific binding affmities for DNA
and are in oligomer forms associated with other factors such as heat shock protein
5
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(hsp90) in the cell (Carson-Jurica, Lee, Dobson, Conneely, Schrader and
O'Malley, 1989; Radanyi, Renoir, Sabbah and Baulieu, 1989; Ratajczak, Comber
and Hahnel, 1988; Rexin, Busch, Segnitz and Gehring, 1988; Ziemiecki, Catelli,
Joab and Monchannont, 1986; Housley, Sanchanz, Westphal, Beato and Pratti,
1985; Schuh et al., 1985).
Upon steroid binding, the receptors undergo an "activation" process that"
dissociates the receptors from hsp90 and possibly small activation inhibitors
(Gustafsson, Ann-Charlotte and Denis, 1989; Orti, Mendel and }'1unck, 1989;
Sato, Nishizawa, Meada, Noma, Honma and Matrumoto, 1983; Sato, Noma,
Nishizawa, Nakao, Matsumoto and Yamamura, 1980). Breaking up the disulfide
bridge may be involved in this dissociation procedure since there is evidence that
sulfhydryl reducing reagents stimulated the receptor activation (MacDonald and
Leavitt, 1982). Activation not only changes the configuration of the receptor
from oligomer into monomer or dimer state, but also increases the binding affinity
between the hormone and receptor and enables the steroid hormone-receptor
complex to bind to specific DNA sequences with a high affinity (de Boer, Lindh,
Bolt, Brinkmann and Mulder, 1986). Generally, a shift of sedimentation
coefficient of the receptors from 7-12 Svedberg units (S, IS = 10-13 seconds) to
4-5S can be observed as a result of the activation (Milgrom, 1981, review).
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Activated steroid honnone receptor binds DNA with two "zinc fmger"
structures located inside its DNA binding domain (Evans and Hollenberg, 1988).
Mutations that delete or insert amino acids in these zinc fmgers result in a non-
functional receptor (Giguere, Hollenberg, Rosenfeld and Evans, 1986). In vitro
evidence suggested that zinc binding is required for high affmity receptor-DNA
binding (Sabbah, Redeuilh, Secco and Baulieu, 1987). Swapping zinc fmgers
among different receptors will change their specific DNA binding sequences
respectively (Danielsen, Hinck and Ringold, 1989; Green, Kumar, Theulaz, Wahli
and Chambon, 1988). Further, specific amino acids within the second, N-
tenninal, zinc rmger that determine target gene specificity also have been
identified by point mutation (Umesono and Evans, 1989).
The specific steroid honnone receptor binding DNA sequences, steroid
honnone response elements (SRE or HRE), function 'as enhancers that primarily
serve to increase the translation rate of adjacent genes. The effectiveness of HRE
is not linearly related with its distance from target structure gene (Beato, 1989,
review). SRE for glucocorticoid, androgen, progestin and estrogen have been
identified in many inducible genes by gene transfer techniques (Yamamoto, 1985,
review). The steroid responses expressed in SRE transferred cells suggested a
direct interaction between steroid hormone receptor and DNA (Berg, 1989). This
interaction leads to changed protein profIles of target cells and, therefore, provides
7
the biochemical bases for various physiological and behavioral responses to
steroid hormones. Some of these responses could lead to permanent changes in
the gene expression pattern of the target cells if the hormone exposure was given
in an early stage of the body's development (Normand, Jean-Faucher and Jean,
1990).
Sexual Hormones and Aggression
One good model for studying steroid hormone regulated behavior is
testosterone (T)-dependent aggression, a system that been actively researched for
more then forty years. Our knowledge of molecular processes of steroid
hormones, neural target tissues of the hormones, and genetic variations in
responsiveness to the aggression-promoting properties of steroids makes
aggression one of the more mature fields of behavioral endocrinology.
An individual's aggressive behavior could include anything from hostile
language to deadly fight. It is expressed in response to many types of cues and
in a variety of behavioral contexts (McGregor and Ayling, 1990; Parmigiani and
Brain, 1983; Goldsmith, Brain and Benton, 1978; Connor and Lynds, 1977;
Crawley, Schleidt and Contrera, 1975; Goyens and Noirot, 1975; Jones and
Nowell, 1975, 1973; Poole and Morgan, 1973; Cairns and Nakelski, 1971;
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Garattini and Sigg. 1969. review). Brian (1979) has distinguished five types of ,~
rodent aggression: (1) self-defense ("fear"-mediated attack); (2) maternal
aggression; (3) predatory aggression (aggressive behavior provoked by situations
such as food competition); (4) pup-killing; (5) social aggression (intrasex attacks
over territory or social rank) (Blanchard. R .• Flannelly. and Blanchard. D .• 1988;
Floody. 1981. review; Vale. J.R.• Vale. C.A. and Harley. 1971; Lagerspetz. 1969,
review. 1961). To this list should be added the attack of a lactating female (Haug
and Brain, 1979; Haug and Mandel, 1978). This classification is somewhat
arbitrary because aggression is not an unitary phenotype. Cues for one type of
aggressive behavior may elicit other types (Albert. Jonik. Walsh and Petrovic,
1989; Albert, Dyson. Walsh and Wong, 1988).
Of these categories of aggression. social aggression by males and maternal
aggression are steroid hormone dependent (Haug, Brain and Kamis, 1986.
review). and only the former. physical attack by one animal on another animal of
the same sex over territory, is "male-typical" for mammals. Social aggression is
then often referred as "intermale" aggression, "male-typical" aggression or "male-
like" fighting.
It is misleading to say that the male is the aggressive sex. Female animals
are not always subordinate to male conspecifics, even when individuals of the two
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sexes compete directly (Floody, 1981, review). Female mice were even more
aggressive when confronted with immature opponents (Gray, Whitsett, and
Ziesenis, 1978; Edwards, 1969), when tested in their home cages with strange
males (Hedricks and Daniels, 1981), or when housed in unisexual groups and
presented with lactating intruders (Haug and Mandel, 1978). Female rodents
could also show "male-like" aggression after certain steroid hormone treatments.
The dependence of intermale aggressIOn on steroids has been well
established since the late 1940s with experiments done mostly in house mice and
rats (Svare, 1983, review). T, the principle circulating androgen in the body, was
the first steroid hormone shown to facilitate aggressive behavior in rodents
(Beeman, 1947). This effect of T can be reliably shown by castration and
sub~equent T therapy on male mice or rats. By removing the testes, the T
releasing glands, intermale aggression is reduced in rats and mice. The reduced
aggression level can be restored to the intact level by T administration (Beeman,
1947; Whalen and Johnson, 1987; and many others).
Identifying T as a male-typical aggression-promoting agent gave insight
into the sexual differentiation of this behavior. Endogenous release of T in males
during the perinatal period is a phenomenon lacking in females. Researchers
showed that the fIrst appearance of aggressive behavior in males coincides with
10
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the first pubertal rise in T secretion (Barkley and Goldman, 1977a,b; McKinney
and Desjardins, 1973; Brain and Nowell, 1969). Experiments with neonatally
castrated male mice showed decreased responsiveness to testosterone propionate
(TP) treatment in adult (vom Saal, Gandelman and Svare, 1976). It was also
demonstrated that neonatally T treated female mice, after ovariectomy as adults,
would readily show male-like fighting when treated with T (Edwards, 1968).
Prenatal and neonatal T exposure also exerted significant effects on other
behaviors in mice (Perrigo, Bryant, and vom Saal, 1989; de Jonge, Muntjewerff,
Louwerse, and Poll, 1988; Vadasz et ai., 1988). It was thus theorized that
perinatal or neonatal testosterone exposure differentiates the male brain by a
process of neural sensitization (masculinization and defeminization of the brain),
such that adult males are more responsive to T then adult females (vom Saal,
1979; Gandelman, 1980, review; Clemens, Gladue, and Conoglio, 1978; Gorski,
Gord~n, Shryne, and Southan, 1978).
This sehsitization theory was supported by experiments that'induced male-
typical aggression in non-neonatally androgenized female mice or rats. In one
i
report, both male and ~emalemice were gonadectomiz~dwithin'the first 12 hours
of life and exposed to TP or oil on Postnatal Day 0, 3, 6 or 12. The mice were
then treated with T implants on Postnatal Day 60 and tested for fighting behavior
every other day for a maximum of 62 days. Virtually all animals in this
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experiment fought despite whether they were exposed to TP neonatally. The
differences among these animals were that those who received neonatal androgen
treatments fought sooner then those who had not been treated with androgen
neonatally (vom Saal, Svare and Gandelman, 1976).
Evidence showed that with chronic T treatment, ovariectomized adult
females would attack against an intruder of both sexes (Albert, Jonik and Walsh,
1990; Albert, Jonik, Walsh and Petrovic, 1989; Whalen and Johnson, 1988;
Whalen and Johnson, 1987; Barkley and Goldman, 1978, 1977c; Simon and
Gandelman, 1978a; Svare, Davis and Gandelman, 1974). These chronic
,
treatments did not seem to produce permanent changes in female mice's
apparently low level of androgen sensiti~ity (vom Saal, Gandelman, an~ Svare,
/--' 1976), although they can, temporarily reduce responsive threshold to subsequent,
more modest androgen therapies. Prenatal or neonatal T exposure is thus not
required for T dependent male-typical aggression but for establishing sensitivity
to the aggression-promoting property of T. It was suggested that early exposure·
to T reduces the thr~shold of the neural systems involved in intermale aggression
. to activation by T in the adult (Gandelman, 1980).
It was however not clear whether T-dependent aggression was androgen
induced or estrogen induced until mid 80s because T has two predominant
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metabolites, dihydrotestosterone (DHT) and estradiol (EJ. The fonner is an
active androgen and the later the primary estrogen in the body. The principal
enzymes involved in these T metabolisms are Sa-reductase that modifies T into
DHT and aromatase that converts T into E.z. Both enzymes are present in the
nervous system (Melcangi, Celotti, Ballabio, Poletti and Martini, 1990; Melcangi
et ai., 1988; Hutchison and Stenner, 1984; Huchison and Stermer, 1981; Jouan,
and Samperez, 1980; Naftolin et ai., 1975; Naftolin, Ruan, and Petro, 1972).
Although T is the predominant circulating androgen in most mammals, its
metabolites, released from peripheral target and nontarget tissue, are available for
uptake and further metabolism by brain (Luttge, 1983, 1979). The magnitude of
this androgen metabolism clearly complicates the' interpretation of behavioral
,
studies employing administration of T.
A· once widely accepted theory of T function was the aromatization
hypothesis.· The theory proposed that T serves as a prohonnone of E.z within
target cells that contain aromatase. The implication of this hypothesis in the study'
of T-dependent aggression study is that it is E.z instead of T that activates fighting
behavior (Beatty, 1979).
Three lines of experimental results suggested that 'E:2 played an important
role in T-induced aggression. First, antiestrogens such as CI-628 had shown
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repressive effects on the aggression-inducing capacity of T (Clark and Nowell,
1979) while flutamide (ITA), an antiandrogen, did not significantly reduce the
recovering of aggression of castrated male mice by methyltestosterone (MT)
(Heilman, Brugmans, Greenslande and DaVanzo, 1976); Second, aromatase
inhibitors, chemicals that eliminate the activity of aromatase, also suppressed the
effect of T on male mice aggression (Bowden and Brain, 1978). Finally,
administration of estrogens such as estradiol benzoate (EB) to castrated male mice
enhanced aggressive behavior, an effect similar to that of T (Simon and
Gandelman, 1978a, 1978b; Edwards and Burge, 1971).
An important discovery questi<:ming the aromatization hypothesis was-also
reported in a third line of experim.tents. Unlike T, chronic EB treatment was
t1
ineffective' of inducing male-like fighting in ovariectomized female mice unkless
those females had received either neonatal androgen or estrogen exposure (Simon
, .
and Gandelman, 1978a; Edwards and Burge, 1971). The failure of EB treatme:Q.t
to mimic T therapy in adult female mice suggested a non-es~ogenic mechanism
of T-dependent aggression.
The estrogenic pathway was not the only activational process for intermale
aggression. Evidence of a direct androgenic action in T-dependent aggression
began emerging shortly after late 70s. Nonaromatizable androgens, androgens
14
.,
that cannot be modified in vivo into estrogens, such as DHT and methyltrienolone
(RI881, a synthetic androgen), mimic the aggression-prompting properties of T
in both male and female mice (Simon and Whalen, 1986; Schechter, Howard and
Gandehnan, 1981). 11ER-25, an antiestrogen, did not inhibit the restoration of
aggression by T in castrated R-S male mice, while cyproterone acetate, an
antiandrogen, reduced the ability of T to stimulate aggression in SPF male mice
(Simon, Gandelman and Howard, 1981; Kurischoko and Oettel, 1977). More
recent evidence suggested that some aromatization inhibitors may suppress T
induced aggressive behavior by direct blocking androgen receptor (Kaplan and
McGinnis, 1989). Additional work showed that androgens, including j
-
_nonaromatizable androgens, are aggression-promoting ~gents in ovariectomized I·
adult female mice, and estrogens, including ~ the alleged active aggression
~ ~ ~
prompting agent of T, are not (Simon, Whalen and Tate, 1985; van de Poll, de
Jonge, v':ill Oyen, van Pelt and de Bruin, 1981).
The controversy over active agents of T has highlighted the importance of
genotype in behavioral endocrinology (Sehnanoff and Ginsburg, 1981). Apparent
conflicting findings could correspond to each other once genetic variations were
consid~c,;,} For example, it was suggested that T induces and maintains
aggression'~gh both androgenic and estrogenic systems (Simon and Whalen,
'"
J
1986). The androgenic pathway exists in both male and female mice with males
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having a higher sensitivity level. The estrogenic pathway, which apparently is
established by neonatal exposure to estrogen, exists only in male mice normally
(Simon and Gandehnan, 1978a). If one pathway is impaired in a strain, the
agents interfering with the remaining pathway would inhibit the aggression-
promoting properties of T.
Impaired steroid hormone processes, though abnormal, are not rare in
laboratory rodents. A host of defects can cause steroid hormone insensitivity
(hormone resistance) (Verhoeven and Wilson, 1979). Most of them are defects
in intracellular proce~ses of steroid hormones. Indeed, "the concept of hormone
resistance has served as a major stimulus for the study of how hormone act within,
cells." (V~rhoeven and Wilson, 1979) and some of the sources of such resistarice
I _
are disc1]ed~elow. .
Steroid Hormone Resistance
Steroid hormone resistance means target tissue cannot respond to normal
or increased levels of a steroid. Individuals with syndromes of hormone
resistance do not necessarily imply an abnormality at the level of the target cell.
Many of them suffer from low level of normal endogenous hormone that can be
successfully treated with steroid administration. True hormone resistance is the
16
"result of genetic mutations that inhibit intracellular steroid honnone function as
outlined in "Steriod Ronnone Action" above.
Abnonnal receptor is the most frequently reported cause for steroid
insensitivity. One of the best documented cases was testicular feminization (Tfm)
or complete androgen insensitivity. The Tfm mouse has normal serum T level but
fails to develop a male phenotype due to lack of a fully functional androgen
receptor (AR) (Bardin and Caterall, 1981; Verhoeven and Wilson, 1976). Several
forms of this condition have been described, and these are represented below.
I
AR .in some Tfm mice are partially deleted. AR, consis1ing of more then
- '-
900 amino acids, is one of the largest steroid hormone receptors as suggested by
the cDNAs of human and rat AR (Liao, Kokontis, Sai and Kipakka, 1989; Tan '
I
et aI., 1988; L':lbahn et. a.I., 1988). Gel-fIltration and· sucrose density gradients
estimated the S'ize of a' wild-type mouse AR at 53A (4.6S) with a molecular
weight CMr) of more than 100 kilo-Dalton (KD); AR from Tfm mouse meanwhile'
was significantly smaller with a size of 38A (3.8S) and a ~ of 66KD as
measured by the same procedure (Young, Johnson, Prescott and Tindall, 1989).
With the elucidation of protein sequences of steroid receptors, it is possible
to analyze whether a less gross mutation in the receptor gene is responsible for
17
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syndromes of steroid resistance. Point mutation (change of one base pair in the
gene) has been reported in Tim Stanley-Gumbreck rat (Yarbrough, Quarmby,
Simental, Olsen and French, 1989), an androgen-insensitive individual (Lubahn,
Brown, Simental, Higgs, Migeon and French, 1989) and possibly in a family
(Brown, Goss, Lubahn, Joseph, Wilson, French and Willard, 1989). These studies
suggested that abnormal receptor often might be due to point mutations rather
than gross structural alterations of the receptor gene.
Besides loss of steroid binding capacity, another effect of an abnormal
receptor is reduced DNA binding ability of the honnone-rec,eptor complex due to
~ '0"
activation defects. Reduced DNA binding was re~orted fo:cER in the mammary
glands from lactating mice, an estrogen insensitive tissue (Gaubert, Carriero and
Shyamala, 1986). In an estrogen-unresponsive cell line (HEC-50), estrogen
~eceptors (ER) were unable to change its conformation into a DNA binding form .
after steroid binding (Kassan, Mechanick and Gurpide, 1989). In another study,
genital skin fibiroblasts from two androgen insensitivity (AI) patients were found
with AR that had nonnal steroid binding property but could not be activated in
vitro (Kaufman, Pinsky, Simard and Wong, 1982).
Abnonnal intracellular steroid hormone receptor level is another reported
possible cause for steroid hormone resistance. With cell lines expressing different
18
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levels of glucocorticoid receptor, Vanderbilt, Miesfeld, Maler and Yamamoto
(1987) had demonstrated that the activity of glucocorticoid response elements
(GREs) was roughly proportional to the number of receptors per cell. Increased
AR concentration, on the other hand, has been related with complete androgen
insensitivity (Hughes, Evans, Ismail and Matthews, 1986).
The relationship between intracellular receptor level and hormone
responsiveness is not always as clear as defmed above. It has been suggested that
not all cytoplasmic steroid hormone receptors are functional (Gorski and Gannon,
1916, review). Receptors that can bind with steroid hormone, for example, may
•
not be able to bind DNA.
\
Steroid hormone resistance also may be rooted in defects in a particular
,
steroid action, especially native steroid hormones that have higher normal binding
affmity with receptor. Several studies indicated that binding affinity of the steroid
hormone-receptor complex, such as the dissociation rate of the hormone-receptor
complex, rather than binding capacity of the receptor, is a more critical iridex of
hormonal sensitivity (Spilman, Wilks and Campbell, 1984; Weichman and
Notides, 1980). These researches suggested that a higher receptor binding affmity
represents a higher biological potency. DHT, for instance, has a higher binding
affmity with androgen receptor then T (Zakar and Toth, 1980). DHT, therefore,
19
often acts as the active androgen. Deficiency in Sa-reductase could then lead to
incomplete virilization of the external genitalia (George and Peterson, 1988).
Pinsky, Kaufman and Chudley (1985) found that an individual of partial androgen
resistance was characterized by AR with reduced binding affmity for DHT even
though binding affmity for R1881 was normal.
Little molecular research has been conducted to examine the causes for
insensitivity to aggression-promoting effect of steroid hormones. It is not enough
just observing different responses to hormone treatments among resistant and
"
r normal genotypes. Cellular, and subcellular, biochemical studies have to be done
to reveal underlying biological mechanisms of steroid hormone-dependent
,. ~
, behaviors such as aggression and relevant target tissue should be identified prior
-, to any work.
\
.I
Hypoth~amusand Aggression
""\ '
I '
The hypothalamic region is an area with effects on a great variety of
behaviors. There is almost no behavioral pattern that can be evoked by
stimulating other parts of the b:am that has not also been obtained from
hypothalamus (Jiigens, 1974, review). The hypothalamus merges caudally with
the periventricular gray and the tegmentum of the mesencephalon. Rostrally the
20
hypothalamus is coupled with the preoptic area, which is often considered a
rostral continuation of the hypothalamus because the similarities in histological
structure and fiber connections between the two. Lying anterior and rostral to
these two structures is the septum. The hypothalamus represents the integrative
link between the central nervous system and the endocrine system by releasing
stimulators or inhibitors that regulate pituitary hormones that in tum regulate all
other hormone releasing glands in the body.
There was strong evidence suggesting that the hypothalamic-septal area
""
was a primary steroid hormone target tissue involved in T-induced aggressive
/
behavior. Receptors for all aggression-promoting steroid hormones exist: in the
hypothalamus; physical damage in this area could abolish animals' T-induced
aggression; and steroid implant in this area has simila: effects of steroid honnone
administrltion on aggressive behavior.
','
.. Hypothalamus is one of the most steroid honnone receptor rich tti;imes in
the brain eVertes, Barnea, Lindner and King, 1973). Significantly greater
selective uptake of tritium labelled DHT eeHJDHT) has been shown in two
strains of mice in the medial basal and preoptic-anterior hypothalamus compared
to the uptake in other brain regions. (Luttge, Grant and Gray, 1976). Two hours
after eHJDHT injection in adult orchidectomized mice, the most heavily labeled
21
,"
(>9 times the background) neurons were found in the hypothalamus and adjacent
)
/
septal-preoptic region by autoradiography (Sheridan, 1978). The same
autoradiography study also showed that heavy [3H]~ uptake was only found in
hypothalamus and septal-preoptic area.
Owen, Peters and Bronson (1974) conducted intracranial TP implants
experiments with castrated adult CF-1 male mice. Animals who received bilateral
implants of total 10-27 pg TP in septum and preoptic-anterior hypothalamus
fought significantly more than those who received implants in neocortex, lateral
ventricles, hippocampus and medial reticular fonnation. Similar restoration of ...
.
intennale aggression recovering also was reported from medial hypothalamic TP
ll.nplant experiments conducted with castrated rats (Albert, Dyson and Walsh, ~ r
--
..
1987).
...
The role of hypothalamus in aggression has also been confinned by lesion ~
and electrical stimulation experiments. Lesions of the medial and anterior ~
hypothalamic area decreased intennale and maternal aggression in rats (Hansen,
1989; Albert, Dyson, Walsh and Gorzalka, 1987; Olivier, Olivier-Aardema and
Wiepkema, 1983). It is interesting to note that lesions in this area coui'd often
facilitate other type of aggression such as shock-induced defensive aggression
(Albert and Walsh, 1984, review). These [mdings illustrated that aggr~ssion is
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not a singular phenotype and different neural pathways may be involved.
Kruk et al. (1984) have demonstrated that electrical stimulation in the
hypothalamus elicits male-typical fighting in both castrated male and
ovariectomized female rats. Upon computer-assisted analysis of "negative" and
aggression-inducing electrode placements in the hypothalamus, they concluded
that the male-like aggressive behavior of male and female rats seemed to be
derived from the same neural systems and no sex differences could be detected
in the sensitivity of these neural systems to the stimulation. Their results
suggested that the neural substrates involved in social aggression are similar in
both sexes.
With the hypothalamus and adjacent septal-preoptic area proposed as the
target tissue for the induction of aggression by steroid hormones, biochemical
studies are now possible to explore the cellular mechanisms in individuals who
respond to the aggression-promoting properties of sexual hormones. The potential
of this combined biochemical and behavioral approach were demonstrated by
work with CD-I, CF-1 and CFW male mice (Chen and Simon, 1990; Simon and
Whalen, 1986).
Behavioral tests were first conducted to examine CD-I, CF-1 and CFW
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males' responses to the aggression-prompting properties of androgen and estrogen.
The results suggested that CD-l is androgen (T, DHT but not R1881) "positive"
and estrogen (~) "negative", CFW is estrogen~) "positive" but androgen
"negative" (DHT and R1881, but positive to aromatizable androgen T), while CF-
1 responded positively to all the estrogen and androgen tested (Simon and
Whalen, 1986). These behavioral data provided a model for further molecular
endocrinological studies using CD-l males as the androgenic pathway subject,
CFW as the estrogenic pathway subject, and CF-l as the positive control.
In vitro hormone binding studies with receptors from preoptic-hypothalamic
f
cytosol were then conducted to examine the hypothesis that the insensitivity of
CD-l to estrogen, or the insensitivity of CFW to androgen, is mediated by
abnormal receptor level or low binding affinity in the target cell. It was found
that estrogen "positive" strains shown either a higher estrogen receptor (ER) level
or a higher estrogen-ER binding affinity than estrogen "negative" CD-l (Simon
and Whalen, 1986). In androgen studies, "positive" responses were apparently
characterized by low in vitro androgen-AR binding affInity in hypothalamic
cytosol (Chen and Simon, 1990). These initial results were still inadequate to
draw conclusions regarding how steroid hormones work in the hypothalamus to
motivate aggression but were very encouraging.
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T-induced Aggression in C57BL/6 Female Mice
It is in the same principle of combined behavioral and molecular
aggression research that the present study was designed. Subjects of this study
is adult C57BL/6J female mice. Previous behavioral studies and the hypotheses
are presented in following paragraphs.
C57BL/6J female mice exhibit a distinct pattern of responsiveness to the
aggression-inducing property of steroid hormones. The behavioral studies were
done by Simon and Masters (1987). Ovariectomized adult (50-59 days of age)
C57BL/6J mice were given androgen (T, DHT or RI881), estrogen (estradiol
benzoate, EB) or combined androgen-estrogen (DHT+EB) treatment for a
maximum of 40 days. Aggression tests were conducted every 48 hours after the
beginning of the steroid treatment. Only T treated mice showed male-typical
fighting while all other treatment groups were not aggressive.
The results of Simon and Masters study (1987) identified a new form of
resistance to the aggression-promoting property of sex hormones. It was expected
that EB would not induce T-dependent aggression in adult C57BL/6J females
because neonatal androgen or estrogen treatment is required for establish the
estrogenic pathway of T-induced aggression in female mice (see discussion in
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"Sexual Hormones and Aggression" above). What was unexpected was the
response to DHT and R188I. The C57BL/6J female was the fIrst reported case
in which non-aromatizeable androgens (such as DHT and R1881) had failed to
induce aggression where T had been effective.
The source of the insensitivity to DHT and R 1881 is most likely a pre-
activation defect(s). The insensitivity is not likely caused by a post receptor
activation event because T, which presumably prompts aggression by activating
androgen receptor in female mice, is still effective. The resistance to non-
aromatizeable androgens also cannot be readily explained by the hypothesis that
a synergistic effect of androgen and estrogen is required for provoking aggression
in this strain as has been argued for the case of CD-l females (Finney and Erpino,
1976). This is because combined DHT+EB treatment was ineffective. On this
basis, it was hypothesized that the defect(s) potentially involved the presence of
different binding sites in hypothalamic tissue for T and other non-aromatizeable
androgens. These binding sites could be 1) abnormal AR that could only be
activated by T; or 2) cytoplasmic non-functional binding sites that bind only or
preferentially with non-aromatizable androgens. To test this notion, two ill vitro
androgen-AR binding studies were designed with the intent of characterizing
binding sites for T and DHT in neural tissue from C57BL/6J female mice.
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Experimental Design
Competitive binding assay
The fIrst experiment was a competitive binding assay. The binding
between steroid hormones and their receptors can be represented in the following
equation:
k}
S(teroid) + R( eceptor) :;:::,======~
k_1
S-F~
where k l stands for association rate constant (how quickly the hormone binds with
its receptor), k_1 is the rate constant of the dissociation of the S-R complex, and
both are distinct characters for a given hormone-receptor complex. The ratio of
k_1 over k 1, Kd the equilibrium dissociation constant, represents the binding affinity
between the hormone and receptor. A smaller ~ suggests a larger k 1 (quick
association) and/or a smaller k_1 (slow dissociation), and thus represents a tighter
binding. ~ is defined in EQ. 1.
K.= k_ 1 = [S] [R]
a k. [S-R]
J.
(EQ. 1)
where [S], [R], [S-R] stands for the concentration of S, Rand S-R in equilibrium
condition (when no more S-R can be formed by given levels of S and R)
respectively.
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In a competitive binding assay, two ligands are incubated with their
common receptor (e.g., both DHT and T bind with AR). When two ligands
compete with each other, the resulting concentrations of the ligand-receptor
complexes depend on the relative concentrations of the competitors, and how
tightly they bind with the receptor. This relationship can be derived from EQ. 1
as shown below.
[51-R] _ Kd / S1 [51]
[52-R] - Kd / S2 [52]
(EQ. 2)
Equations presented above assume that only one specific binding site is
present in the system. There are, however, additional sites for steroid hormones
in cytosol from target tissues. Some of these sites are low affinity, non-specific
binding sites that can be washed out after the ligand-receptor incubation by
appropriate detergents. In addition, there also are non-specific binding sites that
cannot be dissociated from bound hormone by normal washing conditions, and
these can be estimated by ligand binding in the presence of excess competitor.
These binding sites are non-saturable binding and usually consist of
macromolecules that are abundant in the cell. Non-saturable binding sites are not
specific receptors because receptors, by defInition, are found in limited number
in the target cell and, thus, can be easily saturated by excess ligand. The equation
should still hold if we cite the specific binding (S-R) in conditions of excess self
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competitors (e.g., tritium labelled DHT binding m the presence of excess of
unlabelled DHT) as O.
There are more complicated cases where the equations will not stand. For
example, the available binding sites, or the characteristics of the binding sites,
might be associated with the level of ligand in the system. One of these cases is
positive cooperative binding in which higher concentration of the ligand may
introduce more, or tighter, binding sites. In competitive binding assay, positive
cooperative binding can be detected when a competing ligand increases the
binding of the other ligand instead of inhibits it.
One implication of the hypothesis for C57BL/6 females' insensitivity to
non-aromatizeable androgens was that T and DHT have different specific binding
sites in the target tissue of C57BL/6 females. This hypothesis would be tested
with a competitive binding assay by observing whether DHT's binding site can
be inhibited by T, and vice versa.
To address these possibilities, there were 4 treatment groups and 24 assay
conditions in the experiment (see Figure 1). Each condition has one tritium-
labelled ligand with or without an unlabelled competitor at different levels. The
four groups were: eH]T with T, eHJT with DHT, eH]DHT with T and [3H]DHT
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with DHT. The dosages of tritium labelled ligands used in each group were fIXed
at 10 nM. The concentrations of the unlabelled competitors ranged from 0 to
1000 nM. Receptors were prepared in the cytosol from preoptic-septal-
hypothalamic tissue from ovariectomized 'adult C57BL/6 female mice.
Without unlabelled competitor (0 oM), the concentration of labelled
binding complex reaches its maximum. In conditions where competitor was much
more concentrated than tritium labelled ligand (e.g., [Sl] = 10 oM and [S2] =
1000 oM) the' concentration of labelled specific binding complex will be inhibited
([S 1-R] =: 0 when [S2] :> [S 1], see EQ. 2) unless the two ligands do not bind with
the same receptor.
Using different concentrations of the competitor would show us whether
cooperative binding exists and enable us estimate the relative binding affInities
of T and DHT with C57BL/6' s AR because hormones with higher binding affInity
will inhibit more competitor's binding under given concentrations of the two
competitor ([Sl-R]/[S2-R] oc Kd/S2IKd/SI in given [Sl] and [S2], see EQ. 2; recall
that higher affinity is associated with smaller K.J).
The experimental data would be analyzed by analysis of vanance
(ANOVA). The statistical analysis would focus on the interaction among tritium
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labelled ligand, the unlabelled competitor and the dosage of the competitors.
Comparisons between labelled ligand with different competitors CeH]DHT with
DHT vs [3HJDHT with T, eH]T with DHT vs [3H]T with T and eHJDHT with
either DHT or T vs [3H]T with either DHT or T) would be also tested. These
statistics would reveal differences in DHT and T in vitro binding and their
interaction.
Sucrose gradient centrifugation analysis
Should T and DHT have different binding profIles in C57BL/6's target
tissue cytosol, it would be of great interest to characterize the binding sites. If the
two androgens have the same binding sites, on the other hand, our hypothesis that
DHT may fail to induce normal confIgurational changes in AR as an indication
of activation should be tested. In either case we need an experimental procedure
to separate the binding complex of T and DHT of possible different sizes or
weight. Sucrose gradient centrifugation provides one of the most useful means
for this purpose. It has been extensively applied to steroid hormone receptor
research since 1966 (see Toft and Sherman, 1975, for a review).
When a macromolecule passes through a homogeneous medium in a
centrifugal field, the rate of its movement can be expressed as a sedimentation
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coefficient in Svedberg units (S) defmed by EQ. 3.
s=J:.. dlnr
cu dt EQ. 3
where ro is the angular velocity of the centrifuge rotor in radians per second (ro =
1t(rpm)/30), r is the distance in centimeters of the sedimenting band from the axis
of rotation, and t is the time of centrifugation in seconds. In a medium of an
appropriate gradient of increasing sucrose concentration, the increasing density
and viscosity along r would cancel the effects of the nonhomogeneous radial field.
The macromolecular band then moves more slowly and is stabilized where its
density is in homology with the medium.
Sucrose gradient centrifugation is a good procedure to test whether T or
DHT binds with the same binding site and, if they do, whether the same structural
effect on the binding site is induced by each ligand. Sucrose gradient
centrifugation can separate hormone receptors with different molecular weights
or the same receptor with different configurations since both weight and size have
effects on the movement of a macromolecule in the centrifugal field. Heavier or
larger molecules will be found closer to the bottom of the centrifuge tube where
sucrose is more dense while the smaller molecules will be close to the top. It
should be noted, though, that macromolecules inseparable by sucrose gradient
may not be identical.
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There were also other reasons to use sucrose gradient centrifugation. This
method gives clear resolution of monomer (4-5S) and oligomer (7-10S) forms of
steroid receptors, and it is a relatively gentle procedure that can use small
quantities of receptors in unpurified cytosol. The later is important because AR
from neural tissue is very scarce and unstable in vitro and thus should be handled
cautiously with as few experimental steps as possible.
Concentrations of the ligands used in this experiment should include at
least a saturating dosage (the concentration at which further adding ligand into
cytosol will not significantly increase specific binding) of tritium labelled ligand
and the ligand with excess unlabelled competitor to estimate non-specific binding
site(s). A factorial design, as in the competitive binding experiment, was
unnecessary and would use animals without justified cause.
The 5 ligand conditions used were 10 nM or 15 nM [3H]DHT alone, 10
nM eH]DHT with excess (l pM) DHT or T as specific binding competitor, and
10 nM [3H]T with 1 pM unlabelled T (Fig. 2). We made these choices based on
the results of the binding assay. The competitive binding experiments suggested
positive cooperativity in DHT binding and a non-saturable DHT binding site(s)
in the presence of excess DHT but not T. The major purpose of using these test
conditions was to characterize DHT cytoplasmic binding in the presence or
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absence of excess DHT or T. The different [3H]DHT dose (10 and 15 nM) would
examine whether the apparent positive cooperative binding was due to increased
binding affmity or new binding sites. The eH]T condition was included as an
independent control.
The data would be analyzed usmg simple comparisons that test the
goodness of fit between collection curves of eH]DHT with DHT and eH]DHT
with T, eH]DHT with and without excess DHT. These comparisons would show
whether there was a new DHT binding site(s) in concentrated DHT condition.
METHODS
Animals
C57BL/6J female mIce were purchased from the Jackson Laboratory
(C57BL/6J, Bar Harbor, MI) and the Charles River Breeding Fann (Wilmington,
MA) at 50-60 days of age. They were maintained in groups of 4-5 in 28 X 18
X 13 cm polycarbonate cages that were lined with hard wood or Pine shavings.
Food and water were available in excess. The colony was maintained on a 12/12
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hour light/dark cycle with lights on at 0700 hr and all maintenance procedures
complied with Federal Guidelines for Animal Care.
Ligands
[3H]T (specific activity = 168 mCi/mmol) and eHJDHT (specific activity
= 179.4 mCi/mmol) were purchased from New England Nuclear (Boston, MA).
Unlabelled T and DHT were purchased from Sigma (St Louis, MO).
Treatments and Cytosol Preparation
All animals were maintained in house for at least one week before any
treatment. At 70-90 days of age, the females were ovariectomized 48 hours prior
to cytosol preparation.
On the day of the assay, animals were sacrificed by cervical dislocation.
The brains were removed and blocked on iced glass. All following procedures
were conducted at 0-4°C unless otherwise mentioned. The hypothalamus, preoptic
area, and septum were was removed in a single block. The section was bordered
posteriorly by the mammillary bodies, laterally by the hypothalamic sulci,
anteriorly by a cut approximately 1.5 mm anterior to the optic chiasm, and
35
rostrally by a diagonal cut from the mammillary bodies to a fmal depth of 3 rom
above the anterior limit of the section, thus including the septal region. These
tissue incorporates the major AR-concentrating nuclei and the proposed
neuroanatomical substrate for social aggression.
Tissues were homogenized (9 section/ml for competitive binding assay, 12
section/ml for sucrose gradient centrifugation) in TEDMG buffer [10 mM Tris
HCl, 1.5 mM N~EDTA, 1 mM dithothreitol, 10 mM sodium molybdate, 20%
(vjv) glycerol, pH=7.4 at O°C] for the competitive binding assay or in TEDG
buffer [10 mM Tris HCl, 1.5 mM N~EDTA, 1 roM dithothreitol, 10% (vjv)
glycerol, pH=7.4 at O°C] for the centrifugation assay. Molybdate was included
in competitive binding buffer because it helps stabilize steroid hormone receptors
and was excluded from the sucrose gradient centrifugation buffer because it
inhibits receptor activation (Noma, Nakao, Sato, Nishizawa, Matsumoto and
Yarnarnura, 1980). After 25-30 strokes in Teflon-glass homogenizers, the
homogenates were centrifuged at 800 X g for 10 minutes in an lEC CENTRA-7R
refrigerated centrifuge using a fixed angle rotor. The pellets of large subcellular
particles were discarded. The supernatants were then centrifuged at 100,000 X
..
g for one hour in a Beckman L8-70 ultracentrifuge using a swinging bucket rotor
(SW50.1). The resulting supernatants were used immediately in the following
experiments as the receptor-containing cytosol.
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Competitive Binding Assay
Aliquots (200 ul) of cytosol were incubated in 5 ml test tubes in a shaking
rack each with 50 ul TEDMG buffer containing 10 nM tritium labelled ligand
(eHJT or eRJDHT) in the presence of 0, 1, 2, 5, '10 or 1000 nM unlabelled
ligand (T or DHT, see Fig. 1) overnight (16-18 hours). The incubation was ended
by adding 250 ul hydroxylapatite (HAP, a protein binding gel) suspension (50/50,
v/v, in TE buffer [10 mM Tris HCl, 1.5 mM N~EDTA, pH=7.4 at O°C]) into
each tube. The HAP cytosol mixture was vortexed for 10 seconds every 10
minutes for 30 minutes. The incubates were then centrifuged using a swinging
bucket rotor for 3 minutes at 800 X g in the IEe centrifuge. The supernatant
containing free steroids was removed by aspiration and the HAP pellet, which
~ - -
contains HAP-bound proteins including AR, was washed 5 times with 2 ml TE
buffer containing 1% polyoxyethylenesorbitan monooleate (Tween-80, a
detergent). Each wash was followed by a 2 minute centrifugation at 800 X g.
Mter the final wash, the walls of the test tubes were wiped with ethanol
and dried with cotton swabs. Radioactive ligand bound with receptors and non-
specific binding sites were extracted from the pellet with 1 ml ethanol in each
tube by vortexing for 10 seconds every 5 minutes for 15 minutes at room
temperature. A 900 u1 aliquot was taken from the tube after centrifugation and
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placed in a 20 ml scintillation vial. The pellet was re-extracted with 1000 ul
100% ethanol and the procedure was repeated. The extracted radioactivity was
measured in a Beckman LS 5801 liquid scintillation system (Beckman LS-8100
counter) after the addition of 10 ml toluene-based scintillation fluor to each
sample. Counting was repeated 3 times and the standard error of each count was
set within 2 per cent.
Protein concentrations of the cytosol were determined using the Bio-Rad
dye binding reagent kit (Bio-Rad Laboratories, Riclunond, CA). The
concentration for each assay ranged from 1.4 to 1.7 mg protein/ml cytosol.
Radioactive counting data (in CPM) were then normalized to fmol ligand
bound/mg protein before statistic analysis. Six independent replicates were
conducted for each assay conditions (a total of 2 radioactive labelled ligands X
2 unlabelled ligands X 6 competitor concentration conditions X 6 replicates = 144
observations) .
Sucrose Gradient Centrifugation
An aliquot of 200 ul cytosol was incubated with 50 ul TEDO with
radioactive labelled ligand in the presence or absence of excess unlabelled ligand
as specific binding competitor for 6 hours. Five incubation conditions were run
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with different combinations ofligand(s) and competitors (15 oM eRJDHT, 10 oM
[3RJDHT, 10 oM [3RJDHT with 1 JIM DHT, 10 oM eHJDHT with 1 JIM T, and
10 oM eRJT with 1 JIM T. see Fig. 2).
After the incubation, the incubates were carefully loaded onto 4.5 ml 10-
20% sucrose gradient medium in 5 ml centrifugation tubes. The gradient was
prepared in TEG buffer [10 mM Tris Hel, 1.5 mM N~EDTA, 10% (v/v)
glycerol, pH=7.4 at OOe] with a Beckman Density Gradient Fonner no longer then
2 hours prior to the centrifugation. The samples were immediately centrifuged
at 100,000 X g for 16 to 18 hours (overnight) in a SW50.1 rotor on the Beckman
L8-70 ultracentrifuge using slow acceleration and deceleration rate. Fractions of
5 drops were collected from each centrifuge tube into 20 ml scintillation vials
through a hole at the bottom of the centrifuge tube that connected with a metal
needle and polyethylene tubing. After finishing each sample tube, the needle and
the tubing were washed with 5 ml acetone followed by 10 ml distilled water. The
presence of tritium labelled honnone in the collected fractions was measured by
scintillation counting in the Beckman LS-8100 counter as described in competitive
binding assay.
There were 3 independent replicates of the 3 conditions without unlabelled
T (15 and 10 nM [3H]DHT, 10 nM CH]DHT with 1 JIM DHT) and 2 independent
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replicates for the 2 conditions using T (10 nM [3H]T and 10 nM eH]DHT with
IpM T). We collected 20 to 22 fractions per tube. The total observations in this
experiment was about 300 (3 eH]DHT without T condition X 3 replicates + 2 T
condition X 2 replicates = 18 sample tubes; 18 sample tubes X 20-22 fractions
per tube = 300).
Protein concentrations of the cytosol were measured as in competitive
binding assay. The concentrations were in the range from 2.2 to 2.4 mg
protein/ml cytosoL Data of this experiment were analyzed in term of
DPM/fraction.
RESULTS
Competitive Binding Assay
The data from each of the replicates were pooled after one-way analysis
of variance found no significant difference among them. The means of each
assay conditions are presented in Table 1 and Figure 3a through Figure 3d.
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The analysis of variance (ANOVA, see Table 2) showed a significant three
factor interaction among the tritium labelled ligand, the unlabelled competitor and
at which concentration the competitor was present in the system (F(5,120) = 3.47,
P < .01). This significant interaction suggested distinct characteristics between
DHT binding and T binding in the cytosol. Other significant statistics found in
the ANOVA include two factor interaction between labelled ligands and the
competitor dosage (F(5,120) = 3.21, P < .01), the interaction between competitor and
the competitor dosage (F(S,120) = 4.42, P < .001), the main effect of competitor
dosage (F(S,120) = 2.35, P < .05) and the main effect of competitor (FO,120) = 7.22,
P < .01). We found no significant interaction between ligand and competitor
types and no main effect of labelled ligands in this assay. Significant statistics
were also found in two of the three comparisons among the four treatment groups
(see Table 3). The effects of DHT on eH]DHT binding were different in
comparson with those ofT on [3H]DHT binding (F(S,120) = 8.15, P < .001). There
was also a significant difference in [3H]T and eH]DHT binding with various
competitor levels whether the competing ligand was DHT or T (F(5,120) = 3.28, P
< .01).
The level of specific T binding as estimated by tritium labelled binding in
the presence and absence of excess (l p.M) unlabelled T in the cytosol for T was
lower then that for DHT (0.81 fInol/mg for the [3H]T condition and 2.98 fInol/mg
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for the [3H]DID' condition). The difference suggested a higher binding affmity
of the DID'-AR binding complex. There were also signs of positive cooperative
binding. Bindings were higher in the presence of 5 or 1000 nM DID' for
CH]DHT and in the presence of 2 nM DHT and T for [3H]T than binding without
competitors.
The most noticeable result was the high level CH]DHT binding (24.33
fmol/mg protein) in the presence of excess unlabelled DHT. The binding site(s)
had some characteristics of non-specific steroid hormone binding. It was
unsaturable and possibly of"low affmity as indicated by the instability of the
binding data. The presence of this DHT binding site(s) was diminished in assay
conditions when T was present.
Sucrose Gradient Centrifugation
The collection curve of each experimental condition is represented in
Figure 4. The high radioactive counting on top portions (fraction number> 12)
of the centrifuge tubes was due to free tritium labelled ligand (less than 1/1000
radioactive labelled ligands were bound). Unbound steroid ligand was on the top,
where the density medium is low, because they are small molecules. Large
labelled binding complexes were in fractions before free ligand (fraction number
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< 12). The means of radioactivity in fraction 1 to 12 are represented in Table 4
and Figure 5.
Planned statistical analyses were not conducted due to large sample
variation (fraction 1-6, 10-12 for 10 nM and 15 nM [3H]DHT sample and all
fractions with excess unlabelled ligands). This was mainly caused by low affmity
non-specific binding. Low binding affinity, which is characteristic of non-specific
binding sites, makes binding unstable and subject to random changes in the
experimental environment. Results will only be presented in the context of means
and standard deviations.
Saturable binding sites for DHT in the cytosol of C57BL/6 female mice
were found before fraction 10. Non-specific binding, as measured by samples
with either excess unlabelled DHT or T, in these fr~ctions are low and close to
background counting. Binding were much more stable in fractions from 7 to 9
for both 10 nM and 15 nM [3H]DHT sample. This suggested a high affmity
specific androgen binding site in these three fractions. The binding sites in
fraction 1 to 9 were saturated by 10 nM DHT since no significant specific binding
increases in the 15 nM [3H]DHT condition.
The profIles of each sample were consistent with competitive binding assay
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in fractions before 12. DHT binding was inhibited by excess T. [3H]T with
excess T generated higher counts than eHJDHT with excess T sample. It was
also consistent with the competitive assay that eHJDHT with 1 pM unlabelled
DHT sample had high, unstable binding in comparison to the [3H]DHT with T
sample. We noticed that this non-saturable binding site did not overlap with high
affmity binding fractions.
DISCUSSION
Result analysis
We have not found significant evidence that would suggest DHT and T
have different specific receptor binding sites in the cytosol. The in vitro binding
ofeHJDHT was inhibited by T, and the binding of eHJT was affected by DHT
in the similar fashion of unlabelled T since the difference between the two eH]T
binding groups was not significant (F(5.120) = 0.07). The total binding levels
(specific binding and non-saturable binding) in the absence of competitor (0 nM
competitor dose) of both DHT and T were comparable (close to 10 fmoVrng
protein). The notion that T binds with the same specific binding site \vas further
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Lsupported by sucrose gradient centrifuge analysis. Excess T inhibited eHJDHT
binding to the same level as that of excess DHT in specific binding fractions.
These results were consistent with the current notion that there is only one AR
(Tilley, Marcelli and McPaul, 1990, review).
We have strong evidence suggesting DHT and T have different binding
characteristics in the C57BL/6J cytosol. The significant interactions among
labelled ligand, unlabelled ligand and dosages of unlabelled ligand were found in
the competitive assay. We attribute this high order interaction to the difference
in the response to different competitors between the [3H]DHT and eH]T. The
major difference was that eH]T had similar dose responses to both DHT and T
but eRJDHT had distinct different dose responses to the two competitor. eH]T
showed smaller (0.09 - 0.81 fInol/mg protein) specific binding. eH]DHT showed
higher specific binding sites (2.98 fInol/mg protein) in the presence of T without
cooperative binding. There were, however, clear sign of positive cooperative
[3H]DHT binding when excess DHT was the competitor. When taking non-
specific binding data (labelled binding in the presence of excess unlabelled T or
DHT) out of ANOVA, the high level interaction was found not significant among
labelled ligand, unlabelled ligand and dosages of unlabelled ligand (F(4.100) = 1.07).
The only significant effect left was the difference between labelled ligands (F(1.100)
= 54.02, P < .001).
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The most significant result of the competitive binding assay, therefore, was
the unusual high level non-saturable unstable [3H]DHT binding found only in the
presence of excess DHT. The existence of this DIIT non-saturable binding was
confirmed by subsequent sucrose gradient centrifugation. High level of [3H]DHT
binding in fraction 10 to 12 was inhibited by T but not DHT. It was unclear
about fractions above 12 because of huge free ligand counts.
This non-saturable DHT binding site(s) was further characterized by the
sucrose gradient centrifuge analysis. First, it had a smaller sedimentation
coefficient than the specific binding site in the cytosol since it did not overlap
with the saturable binding fractions. Second, high concentrations of DHT might
.. not be required for binding to non-saturable sites. Both 10 nM and 15 nM
[3H]DHT sample had comparable unstable binding in fractions 10 to 12.
The finding of such ligand specific non-saturable binding sites was rare but
not unprecedented. There have been reports of binding sites other than receptors
for estrogen (Swaneck, Alvarez, and Sufrin, 1982; Ekman, Barrack, Greene,
Jensen and Walsh, 1983). Similar non-saturable androgen binding sites have also
been reported for R18S1 in canine prostatic epithelial cells using a whole cell
competitive binding assay (Turcotte, Chapdelaine and Chevalier, 1988). In the
R18S1 study, the uptake of 1 nM CH]R1881 by cultured canine prostatic
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epithelial cells was measured in the presence of unlabelled RI881 at
concentrations from 0 to 500 nM. Uptake was significantly (P < 0.05) higher in
the presence of 40 nM (for 17 days cultured cells), 60 nM and 80 nM (for 24
days cultured cells) competing R 1881 than those determined without the
competitor. The fmding of these less specific RI881 binding sites was supported
by a subsequent saturation study. Three R1881 specific binding sites were found,
each saturable at 5, 15 and 30 nM. The 5 nM saturable site was due to AR and
contributed 001)' 11.4% of the total uptake of RI881 by the cells. This and our
studies suggested that androgen binding sites other than the receptor may be
present in both central and peripheral tissue.
Theories on C57BL/6 Females' DHT insensitivity
Our knowledge of the relationship between aggressive behavior and steroid
hormone function in central nervous system (CNS) target tissue is presently very
limited. Few molecular endocrinological studies have been done in this area
mostly because of experimental difficulties due to apparent low and unstable
receptor level in CNS target tissue. Our studies with C57BL/6J female mice
provide the basis for more specific hypothesis for future cellular experiments.
In light of the present results, one suggested theory for C57BL/6 females'
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insensitivity to the aggression-promoting properties of DHT is that the DHT
function in the hypothalamus was interrupted because DHT was blocked away
from specific normal AR binding by large number of non-functional DHT binding
sites in the tissue. It is like a reversed case of receptor blocking by androgen
antagonists in which it is the ligand instead of the receptor being blocked.
Further characterization the DHT non-saturable binding sites would shed
light on the question of above ligand blocking theory. There are at least three
basic aspects of the theory have to be addressed in the future studies. First is the
identity of the binding site. Is it a single site or multiple sites? In the present
studies the answer was unclear because of the presence of free ligand which
makes analysis of small binding sites difficult. Removing these free ligands
before the centrifugation might help solve this problem. Is this site(s) a less
specific DHT autoantibody(s)? The development of antibodies that inactivate or
block the active hormones has been found in certain thyroid hormone resistant
subjects (Ginsberg, Segal and Ehrlich, 1978). A second aspect of the theory is
the specificity and capacity ,of the binding sites. Would it also bind with T or
R1881 that was also inefficient in prompting aggressive behavior in adult
C57BL/6 female mice (Simon and Masters, 1987)? Would it be saturated at a
higher level of DHT, 30 nM, for instance, as the R1881 non-receptor binding sites
in cultured canine prostatic epithelial cells? The third aspect is subcellular
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location of this binding site(s). It would be extracellular if it was an antibody.
If it is intracellular, would it be in the cell plasma or nuclei?
The above questions were asked from a static point of view that can be
addressed by equilibriwn studies like those presented in this thesis. Approaches
that treat cellular steroid hormone function as a continuous event can then be
designed based on the results from these equilibriwn data. One proposed study
is to examine the post-translational events such as the expression of AR gene of
both T and DHT treatments. As a behavioral model, C57BL/6J female mice might
indeed provide a key natural laboratory for studying the androgenic pathway of
T-induced aggression.
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Table 1 Table of Means for Competitive Binding Assay
Competitor Dose (nM)
0 1 2 5 10 1000
[3H]DHT 8.69 7.01 8.35 9.94 6.59 24.33
w/DHT ± .45 ± .22 ± .43 ±2.02 ± .31 ±8.47
[3H]DHT 9.16 8.05 7.86 7.31 6.70 6.18
wiT ±1.24 ± .62 ± .63 ± .40 ± .49 ± .70
eH]T 10.71 10.83 11.25 10.64 10.13 10.62
w/DHT ± .33 ± .68 ±1.31 ± .56 ± .62 ± .46
[3H]T 9.67 9.89 10.79 9.95 10.10 8.86
wiT ± .42 ± .27 ± .44 ± .21 ± .31 ± .68
Note: Tritium labelled ligand dosage was 10 nM. Data shown in fmoVmg protein
(mean ± standard deviation.)
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Table 2 ANOVA for Competitive Binding Assay
SOURCE SS df MS F
MAIN EFFECTS
eH]Ligand 43.94 1 43.94 2.10
Competitor 151.06 1 151.06 7.22**
Dose 245.70 5 49.14 2.35·
INTERACTIONS
eH]Ligand X
Competitor 54.08 1 54.08 2.58
eH]Ligand X Dose 336.28 5 67.26 3.21**
Competitor X Dose 462.49 5 92.50 4.42**·
[3H]Ligand
X Competitor
X Dose 363.65 5 72.73 3.47**
RESIDUAL 2512.5 120 20.94
TOTAL 4169.7 143
Note: • P<.05; .... P<.Ol; .... P<.OO1.
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Table 3 Analysis of Comparisons among Competitive Binding Assay Groups
Source SS df MS F
[3H]DHTIDHT vs
CHJDHTff 853.10 5 170.62 8.15....•
eH]T/DHT vs
eH]T/DHT 7.23 5 1.45 0.07
[3H]DHTs vs
CHJTs 343.61 5 68.72 3.28....
RESIDUAL 2512.46 120 20.94
...... 00.... 0Note: P <. 1; P <. 1.
eH]DHTs: Groups of [3H]T with DHT or T as competitor; eH]Ts: Groups of
[3H]T with DHT or T as competitor.
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Table 4 Table of Means for Sucrose Gradient Centrifugation
# CH]DHT CH]DHT eH]DHT [3H]DHT [3H]T 10nM
15nM 10nM 10nM wi 10nM wi wi
DHTlpM T 1pM T 1 pM
1 196.92 195.92 55.55 13.82 95.85
± 107.03 ± 68.98 ± 16.45 ± 19.54 ± 61.12
2 195.66 154.14 68.77 70.66 126.43
± 115.16 ± 63.76 ± 16.67 ± 16.33 ± 26.43
3 143.95 135.44 58.59 60.57 120.42
± 66.43 ± 76.46 ± 33.63 ± 23.33 ± 47.59
4 128.10 120.89 60.11 65.95 126.51
± 57.92 ± 53.67 ± 22.80 ± 35.01 ± 57.50
5 110.25 129.95 52.58 54.79 87.21
± 52.74 ± 29.06 ± 20.03 ± 17.27 ± 74.30
6 87.58 107.50 56.91 54.07 74.30
± 42.23 ± 44.13 ± 25.90 ± 10.94 ± 13.90
7 84.97 92.45 50.38 66.12 54.57
± 3.96 ± 29.93 ± 16.72 ± 18.55 ± 15.99
8 94.95 103.09 53.20 66.09 48.94
± 9.93 ± 3.82 ± 12.12 ± 22.03 ± 17.45
9 106.71 130.95 77.12 90.97 46.34
± 5.32 ± 4.58 ± 50.67 ± 30.65 ± 13.54
10 162.51 171.85 198.71 119.76 65.51
± 18.03 ± 111.95 ± 240.93 ± 44.92 ± 18.92
11 251.80 905.98 489.48 214.53 63.63
± 187.28 ± 36.08 ± 718.28 ± 22.03 ± 38.66
12 519.12 2251.67 1396.08 230.66 120.72
± 26.63 ± 803.13 ±2173.11 ± 28.09 ± 108.24
Note: # = Fraction number (l = 25% sucrose). Data are shown in DPMs (mean
± standard deviation.)
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Figure 1 Experimental Conditions of Competitive Bineting Assay
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Figure 2 Experimental Conditions of Sucrose Gradient Centrifugation
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Figure 3a [3H]DHT Binding with Unlabelled DHT
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Figure 3b [3H]DHT Binding with Unlabelled T
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Figure 3c [3H]T Binding with Unlabelled DHT
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Figure 3d [3H]T Binding with Unlabelled T
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Figure 4 eHJDHT in Fractions of Sucrose Gradient Centrifugation
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Note: Sucrose gradient (10-25%) centrigufation of 18 hours incubation of
androgens with cytosol of hypothalamus from ovariectomized adult C57BL/6 mice.
"'Om = [3H]DHT; Fraction 1 = 25% Sucrose; Fraction 22 = 10% sucrose.
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Figure 5 Sedimentation Profiles of [3H]DHT Binding in the Presence and Absence
of Unlabelled DHT and T
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Note: Sucrose gradient (10-25%) centrigufation of 18 hours incubation of
androgens with cytosol of hypothalamus from ovariectomized adult C57BL/6 mice.
·DHT = [3H]DHT; Fraction 1 = 10% Sucrose.
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